Search peptides, goals, protocols and references
Growth hormone-releasing factor analogue
A GHRF analogue approved for reduction of excess abdominal fat in adults with HIV and lipodystrophy, with additional research contexts. This record separates established identity and source-linked research context from protocol or commercial fields that are not yet supportable.
PUBLISHED STUDY
No universal administration structure is inferred from the indexed literature. Open the source for the population, intervention and study design.
Tesamorelin stimulates pituitary growth hormone release and downstream IGF-1. Findings in HIV-associated lipodystrophy do not automatically generalize to other body-composition contexts.
A GHRH(1-29) analogue formerly approved for pediatric diagnostic and treatment contexts and later discontinued commercially.
A long-acting growth hormone-releasing hormone analogue studied in healthy adults for GH and IGF-1 pharmacodynamics.
A selective ghrelin-receptor agonist studied as a growth hormone secretagogue, with limited modern human clinical evidence.
THE SIGNAL